These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells. Gammeltoft S; Vinten J; Gliemann J; Linde S Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469 [TBL] [Abstract][Full Text] [Related]
4. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes. Peavy DE; Abram JD; Frank BH; Duckworth WC Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667 [TBL] [Abstract][Full Text] [Related]
5. Potency of biosynthetic human insulin determined in vitro. Fussgaenger RD; Ditschuneit HH; Martini H; Wiebauer-De Lenardis H; Etzrodt H; Thun C; Ditschuneit H; Pfeiffer EF; Enzmann F Diabetes Care; 1981; 4(2):228-34. PubMed ID: 7011733 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 125-I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Olefsky J; Johnson J; Liu F; Edwards P; Baur S Diabetes; 1975 Sep; 24(9):801-10. PubMed ID: 169175 [TBL] [Abstract][Full Text] [Related]
8. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination. Zórad S; Svábová E; Klimes I; Macho L Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407 [TBL] [Abstract][Full Text] [Related]
9. Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin. Haneda M; Kobayashi M; Maegawa H; Watanabe N; Takata Y; Ishibashi O; Shigeta Y; Inouye K Diabetes; 1985 Jun; 34(6):568-73. PubMed ID: 3891469 [TBL] [Abstract][Full Text] [Related]
10. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization]. Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036 [TBL] [Abstract][Full Text] [Related]
11. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency. Sonne O; Linde S; Larsen TR; Gliemann J Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199 [TBL] [Abstract][Full Text] [Related]
12. The effect of insulin on fat cells. An insulin degrading system extracted from plasma membranes of insulin responsive cells. Crofford OB; Rogers NL; Russell WG Diabetes; 1972; 21(2 Suppl):403-13. PubMed ID: 5054326 [No Abstract] [Full Text] [Related]
13. Preparation of isolated bovine adipocytes: validation of use for studies characterizing insulin sensitivity and binding. Vasilatos R; Etherton TD; Wangsness PJ Endocrinology; 1983 May; 112(5):1667-73. PubMed ID: 6299704 [TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative comparison of glucose transport activity and glucose transporter concentration in plasma membranes from basal and insulin-stimulated rat adipose cells. Joost HG; Weber TM; Cushman SW Biochem J; 1988 Jan; 249(1):155-61. PubMed ID: 3277616 [TBL] [Abstract][Full Text] [Related]
15. D-Glucose uptake and insulin binding by the human adipose cell plasma membrane as a function of its polypeptide composition. Brenner BG; Ozaki S; Kalant N; Kahlenberg A Can J Biochem; 1977 Feb; 55(2):126-33. PubMed ID: 843981 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissues. Podlecki DA; Frank BH; Kao M; Horikoshi H; Freidenberg G; Marshall S; Ciaraldi T; Olefsky JM Diabetes; 1983 Aug; 32(8):697-704. PubMed ID: 6347766 [No Abstract] [Full Text] [Related]
17. Insulin receptors in the heart muscle. Demonstration of specific binding sites and impairment of insulin binding in the plasma membrane of the obese hyperglycemic mouse. Forgue ME; Freychet P Diabetes; 1975 Aug; 24(8):715-23. PubMed ID: 169173 [TBL] [Abstract][Full Text] [Related]
18. The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. Salans LB; Dougherty JW J Clin Invest; 1971 Jul; 50(7):1399-410. PubMed ID: 5090056 [TBL] [Abstract][Full Text] [Related]
19. Lysosomal degradation of receptor-bound 125I-labeled insulin by rat adipocytes: its characterization and dissociation from the short-term biologic effects of insulin. Hammons GT; Jarett L Diabetes; 1980 Jun; 29(6):475-86. PubMed ID: 6991335 [TBL] [Abstract][Full Text] [Related]
20. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin. Olefsky JM Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]